MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 12, 2023

Total Value ($000): $384,917 (100.0% shares, 0.0% debt)

Holdings (31)

CGEM Cullinan Oncology, Inc. 20.3%

Value ($000) $78,242 Shares 7,648,268 Est. Cost $40.60 Unrealized -72.8%

— Provention Bio Inc 7.3%

Value ($000) $28,289 Shares 1,173,809 Est. Cost $9.66 Unrealized —

— Iveric Bio Inc 6.6%

Value ($000) $25,442 Shares 1,045,691 Est. Cost $17.94 Unrealized —

— iTeos Therapeutics, Inc. 6.2%

Value ($000) $23,762 Shares 1,745,943 Est. Cost $24.67 Unrealized —

— Inhibrx, Inc Com 5.8%

Value ($000) $22,498 Shares 1,192,281 Est. Cost $12.67 Unrealized —

NTLA Intellia Therapeutics, Inc. 5.5%

Value ($000) $21,336 Shares 572,459 Est. Cost $77.45 Unrealized -49.4%

RLAY Relay Therapeutics Inc. 5.2%

Value ($000) $20,186 Shares 1,225,634 Est. Cost $17.93 Unrealized 0.0%

GERN Geron Corporation 4.7%

Value ($000) $18,231 Shares 8,401,565 Est. Cost $1.34 Unrealized +111.6%

— Reata Pharmaceuticals inc-a 4.3%

Value ($000) $16,545 Shares 176,874 Est. Cost $33.17 Unrealized —

— Repare Therapeutics, Inc. 4.2%

Value ($000) $16,136 Shares 1,639,849 Est. Cost $31.02 Unrealized —

IOVA Iovance Biotherapeutics Inc Com 4.2%

Value ($000) $15,978 Shares 2,614,977 Est. Cost $10.79 Unrealized -36.1%

RGNX REGENXBIO Inc. 3.0%

Value ($000) $11,680 Shares 617,671 Est. Cost $29.67 Unrealized -25.4%

— Verve Therapeutics, Inc 3.0%

Value ($000) $11,586 Shares 803,501 Est. Cost $31.14 Unrealized —

MDGL Madrigal Pharmaceuticals inc 2.3%

Value ($000) $8,731 Shares 36,038 Est. Cost $124.66 Unrealized +118.6%

TVTX Travere Therapeutics Inc. 1.8%

Value ($000) $7,054 Shares 313,642 Est. Cost $18.71 Unrealized +13.6%

QURE Uniqure N.V. 1.8%

Value ($000) $7,013 Shares 348,224 Est. Cost $21.57 Unrealized -2.7%

INSM Insmed Incorporated 1.8%

Value ($000) $6,806 Shares 399,192 Est. Cost $19.33 Unrealized +0.5%

HOWL Werewolf Therapeutics, Inc. 1.6%

Value ($000) $6,209 Shares 2,388,011 Est. Cost $13.70 Unrealized -78.2%

CRNX Crinetics Pharmaceuticals Inc. 1.5%

Value ($000) $5,788 Shares 360,392 Est. Cost $21.64 Unrealized -14.5%

RVMD Revolution Medicines, Inc. 1.4%

Value ($000) $5,350 Shares 247,022 Est. Cost $27.23 Unrealized -9.6%

— TCR2 Therapeutics, Inc. 1.3%

Value ($000) $5,056 Shares 3,370,982 Est. Cost $14.28 Unrealized —

— Chinook Therapeutics, Inc. 1.2%

Value ($000) $4,579 Shares 197,806 Est. Cost $24.38 Unrealized —

AXSM Axsome Therapeutics, Inc. 1.1%

Value ($000) $4,342 Shares 70,402 Est. Cost $61.32 Unrealized +7.1%

FOLD Amicus Therapeutics Inc. 1.1%

Value ($000) $4,306 Shares 388,292 Est. Cost $10.25 Unrealized +20.3%

ARQT Arcutis Biotherapeutics inc 0.7%

Value ($000) $2,796 Shares 254,137 Est. Cost $16.93 Unrealized -14.5%

— Harpoon Therapeutics, Inc. 0.6%

Value ($000) $2,378 Shares 3,196,707 Est. Cost $14.79 Unrealized —

PHAT Phathom Pharmaceuticals inc 0.4%

Value ($000) $1,518 Shares 212,615 Est. Cost $15.50 Unrealized -43.3%

— Inozyme Pharma Inc. 0.3%

Value ($000) $1,339 Shares 233,728 Est. Cost $7.77 Unrealized —

— Oncorus, Inc. 0.2%

Value ($000) $818 Shares 2,377,031 Est. Cost $32.33 Unrealized —

— AVROBIO, Inc. 0.2%

Value ($000) $648 Shares 647,918 Est. Cost $5.58 Unrealized —

BDTX Black Diamond Therapeutics, Inc. 0.1%

Value ($000) $274 Shares 144,888 Est. Cost $9.87 Unrealized -76.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGEM	Cullinan Oncology, Inc.	7,648,268	$78,242	20.3%	$40.60	-72.8%	Common	230031106
—	Provention Bio Inc	1,173,809	$28,289	7.3%	$9.66	—	Common	74374N102
—	Iveric Bio Inc	1,045,691	$25,442	6.6%	$17.94	—	Common	46583P102
—	iTeos Therapeutics, Inc.	1,745,943	$23,762	6.2%	$24.67	—	Common	46565G104
—	Inhibrx, Inc Com	1,192,281	$22,498	5.8%	$12.67	—	Common	45720L107
NTLA	Intellia Therapeutics, Inc.	572,459	$21,336	5.5%	$77.45	-49.4%	Common	45826J105
RLAY	Relay Therapeutics Inc.	1,225,634	$20,186	5.2%	$17.93	0.0%	Common	75943R102
GERN	Geron Corporation	8,401,565	$18,231	4.7%	$1.34	+111.6%	Common	374163103
—	Reata Pharmaceuticals inc-a	176,874	$16,545	4.3%	$33.17	—	Common	75615P103
—	Repare Therapeutics, Inc.	1,639,849	$16,136	4.2%	$31.02	—	Common	760273102
IOVA	Iovance Biotherapeutics Inc Com	2,614,977	$15,978	4.2%	$10.79	-36.1%	Common	462260100
RGNX	REGENXBIO Inc.	617,671	$11,680	3.0%	$29.67	-25.4%	Common	75901B107
—	Verve Therapeutics, Inc	803,501	$11,586	3.0%	$31.14	—	Common	92539P101
MDGL	Madrigal Pharmaceuticals inc	36,038	$8,731	2.3%	$124.66	+118.6%	Common	558868105
TVTX	Travere Therapeutics Inc.	313,642	$7,054	1.8%	$18.71	+13.6%	Common	89422G107
QURE	Uniqure N.V.	348,224	$7,013	1.8%	$21.57	-2.7%	Common	N90064101
INSM	Insmed Incorporated	399,192	$6,806	1.8%	$19.33	+0.5%	Common	457669307
HOWL	Werewolf Therapeutics, Inc.	2,388,011	$6,209	1.6%	$13.70	-78.2%	Common	95075A107
CRNX	Crinetics Pharmaceuticals Inc.	360,392	$5,788	1.5%	$21.64	-14.5%	Common	22663K107
RVMD	Revolution Medicines, Inc.	247,022	$5,350	1.4%	$27.23	-9.6%	Common	76155X100
—	TCR2 Therapeutics, Inc.	3,370,982	$5,056	1.3%	$14.28	—	Common	87808K106
—	Chinook Therapeutics, Inc.	197,806	$4,579	1.2%	$24.38	—	Common	16961L106
AXSM	Axsome Therapeutics, Inc.	70,402	$4,342	1.1%	$61.32	+7.1%	Common	05464T104
FOLD	Amicus Therapeutics Inc.	388,292	$4,306	1.1%	$10.25	+20.3%	Common	03152W109
ARQT	Arcutis Biotherapeutics inc	254,137	$2,796	0.7%	$16.93	-14.5%	Common	03969K108
—	Harpoon Therapeutics, Inc.	3,196,707	$2,378	0.6%	$14.79	—	Common	41358P106
PHAT	Phathom Pharmaceuticals inc	212,615	$1,518	0.4%	$15.50	-43.3%	Common	71722W107
—	Inozyme Pharma Inc.	233,728	$1,339	0.3%	$7.77	—	Common	45790W108
—	Oncorus, Inc.	2,377,031	$818	0.2%	$32.33	—	Common	68236R103
—	AVROBIO, Inc.	647,918	$648	0.2%	$5.58	—	Common	05455M100
BDTX	Black Diamond Therapeutics, Inc.	144,888	$274	0.1%	$9.87	-76.7%	Common	09203E105